Cell-based screening: Extracting meaning from complex data

Neuron

Volumn 86, Issue 1, 2015, Pages 160-174

  Finkbeiner, Steven ^a,b   Frumkin, Michael ^c   Kassner, Paul D ^d  

^a GLADSTONE INSTITUTE OF NEUROLOGICAL DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GOOGLE INC   (United States)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA;

ALGORITHM; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CRISPR CAS SYSTEM; DATA EXTRACTION; DATA SYNTHESIS; GENETIC SCREENING; GENETIC VARIABILITY; HIGH THROUGHPUT SCREENING; HUMAN; HUNTINGTON CHOREA; IMAGE ANALYSIS; MACHINE LEARNING; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; SCHIZOPHRENIA; SPINAL MUSCULAR ATROPHY; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASES; COMPUTER SIMULATION; FACTUAL DATABASE; PHYSIOLOGY; RESEARCH;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; COMPUTER SIMULATION; DATABASES, FACTUAL; HUMANS; INDUCED PLURIPOTENT STEM CELLS; RESEARCH;

EID: 84930324062     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2015.02.023     Document Type: Review

References (147)

1. Abyzov A., Mariani J., Palejev D., Zhang Y., Haney M.S., Tomasini L., Ferrandino A.F., Rosenberg Belmaker L.A., Szekely A., Wilson M., et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 2012, 492:438-442.
2. Actis P., Maalouf M.M., Kim H.J., Lohith A., Vilozny B., Seger R.A., Pourmand N. Compartmental genomics in living cells revealed by single-cell nanobiopsy. ACS Nano 2014, 8:546-553.
3. Al-Ali H., Blackmore M., Bixby J.L., Lemmon V.P. High content screening with primary neurons. Assay Guidance Manual [Internet] 2013, Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, MD. G.S. Sittampalam, N.P. Coussens, H. Nelson, M. Arkin, D. Auld, C. Austin, B. Bejcek, M. Glicksman, J. Inglese, V. Lemmon, Z. Li, J. McGee, O. McManus, L. Minor, A. Napper, T. Riss, O.J. Trask, J. Weidner (Eds.).
4. Ambasudhan R., Talantova M., Coleman R., Yuan X., Zhu S., Lipton S.A., Ding S. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell 2011, 9:113-118.
5. Arrasate M., Finkbeiner S. Automated microscope system for determining factors that predict neuronal fate. Proc. Natl. Acad. Sci. USA 2005, 102:3840-3845.
6. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004, 431:805-810.
7. Aubry L., Bugi A., Lefort N., Rousseau F., Peschanski M., Perrier A.L. Striatal progenitors derived from human ES cells mature into DARPP32 neurons invitro and in quinolinic acid-lesioned rats. Proc. Natl. Acad. Sci. USA 2008, 105:16707-16712.
8. Barmada S.J., Skibinski G., Korb E., Rao E.J., Wu J.Y., Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J.Neurosci. 2010, 30:639-649.
9. Barmada S.J., Serio A., Arjun A., Bilican B., Daub A., Ando D.M., Tsvetkov A., Pleiss M., Li X., Peisach D., et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat. Chem. Biol. 2014, 10:677-685.
10. Bates M., Huang B., Dempsey G.T., Zhuang X. Multicolor super-resolution imaging with photo-switchable fluorescent probes. Science 2007, 317:1749-1753.
11. Bates M., Huang B., Zhuang X. Super-resolution microscopy by nanoscale localization of photo-switchable fluorescent probes. Curr. Opin. Chem. Biol. 2008, 12:505-514.
12. Bendall S.C., Simonds E.F., Qiu P., Amir A.D., Krutzik P.O., Finck R., Bruggner R.V., Melamed R., Trejo A., Ornatsky O.I., et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011, 332:687-696.
13. Berger B., Rothmaier A.K., Wedekind F., Zentner J., Feuerstein T.J., Jackisch R. Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex. Br. J. Pharmacol. 2006, 148:795-806.
14. Bhinder B., Djaballah H. Systematic analysis of RNAi reports identifies dismal commonality at gene-level and reveals an unprecedented enrichment in pooled shRNA screens. Comb. Chem. High Throughput Screen. 2013, 16:665-681.
15. Bilican B., Serio A., Barmada S.J., Nishimura A.L., Sullivan G.J., Carrasco M., Phatnani H.P., Puddifoot C.A., Story D., Fletcher J., et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc. Natl. Acad. Sci. USA 2012, 109:5803-5808.
16. Birmingham A., Selfors L.M., Forster T., Wrobel D., Kennedy C.J., Shanks E., Santoyo-Lopez J., Dunican D.J., Long A., Kelleher D., et al. Statistical methods for analysis of high-throughput RNA interference screens. Nat. Methods 2009, 6:569-575.
17. Blow N. Systems biology: Untangling the protein web. Nature 2009, 460:415-418.
18. Boulting G.L., Kiskinis E., Croft G.F., Amoroso M.W., Oakley D.H., Wainger B.J., Williams D.J., Kahler D.J., Yamaki M., Davidow L., et al. Afunctionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 2011, 29:279-286.
19. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., Li Y., Mu Y., Chen G., Yu D., et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473:221-225.
20. Burkhardt M.F., Martinez F.J., Wright S., Ramos C., Volfson D., Mason M., Garnes J., Dang V., Lievers J., Shoukat-Mumtaz U., et al. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol. Cell. Neurosci. 2013, 56:355-364.
21. Carlson E.A., McCulloch C., Koganti A., Goodwin S.B., Sutter T.R., Silkworth J.B. Divergent transcriptomic responses to aryl hydrocarbon receptor agonists between rat and human primary hepatocytes. Toxicol. Sci. 2009, 112:257-272.
22. Castan I., Valet P., Quideau N., Voisin T., Ambid L., Laburthe M., Lafontan M., Carpéné C. Antilipolytic effects of alpha 2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammal adipocytes. Am. J. Physiol. 1994, 266:R1141-R1147.
23. Chambers S.M., Mica Y., Lee G., Studer L., Tomishima M.J. Dual-SMAD inhibition/WNT activation-based methods to induce neural crestand derivatives from human pluripotent stem cells. Methods Mol. Biol. 2013, Published online December 4, 2013. 10.1007/7651_2013_59.
24. Choi S.H., Kim Y.H., Hebisch M., Sliwinski C., Lee S., D'Avanzo C., Chen H., Hooli B., Asselin C., Muffat J., et al. A three-dimensional human neural cell culture model of Alzheimer's disease. Nature 2014, 515:274-278.
25. Choulier L., Enander K. Environmentally sensitive fluorescent sensors based on synthetic peptides. Sensors (Basel) 2010, 10:3126-3144.
26. Chudakov D.M., Lukyanov S., Lukyanov K.A. Tracking intracellular protein movements using photoswitchable fluorescent proteins PS-CFP2 and Dendra2. Nat. Protoc. 2007, 2:2024-2032.
27. Chudakov D.M., Matz M.V., Lukyanov S., Lukyanov K.A. Fluorescent proteins and their applications in imaging living cells and tissues. Physiol. Rev. 2010, 90:1103-1163.
28. Churko J.M., Burridge P.W., Wu J.C. Generation of human iPSCs from human peripheral blood mononuclear cells using non-integrative Sendai virus in chemically defined conditions. Methods Mol. Biol. 2013, 1036:81-88.
29. Clarke G., Collins R.A., Leavitt B.R., Andrews D.F., Hayden M.R., Lumsden C.J., McInnes R.R. A one-hit model of cell death in inherited neuronal degenerations. Nature 2000, 406:195-199.
30. Collinet C., Stöter M., Bradshaw C.R., Samusik N., Rink J.C., Kenski D., Habermann B., Buchholz F., Henschel R., Mueller M.S., et al. Systems survey of endocytosis by multiparametric image analysis. Nature 2010, 464:243-249.
31. Conrad C., Erfle H., Warnat P., Daigle N., Lörch T., Ellenberg J., Pepperkok R., Eils R. Automatic identification of subcellular phenotypes on human cell arrays. Genome Res. 2004, 14:1130-1136.
32. Cooper O., Seo H., Andrabi S., Guardia-Laguarta C., Graziotto J., Sundberg M., McLean J.R., Carrillo-Reid L., Xie Z., Osborn T., et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci. Transl. Med. 2012, 4:141ra190.
33. Cronin S.J.F., Nehme N.T., Limmer S., Liegeois S., Pospisilik J.A., Schramek D., Leibbrandt A., Simoes Rde.M., Gruber S., Puc U., et al. Genome-wide RNAi screen identifies genes involved in intestinal pathogenic bacterial infection. Science 2009, 325:340-343.
34. Crook Z.R., Housman D. Huntington's disease: can mice lead the way to treatment?. Neuron 2011, 69:423-435.
35. Curtis S.W., Shi H., Teng C., Korach K.S. Promoter and species specific differential estrogen-mediated gene transcription in the uterus and cultured cells using structurally altered agonists. J.Mol. Endocrinol. 1997, 18:203-211.
36. Czepiel M., Balasubramaniyan V., Schaafsma W., Stancic M., Mikkers H., Huisman C., Boddeke E., Copray S. Differentiation of induced pluripotent stem cells into functional oligodendrocytes. Glia 2011, 59:882-892.
37. Daub A., Sharma P., Finkbeiner S. High-content screening of primary neurons: ready for prime time. Curr. Opin. Neurobiol. 2009, 19:537-543.
38. Dekker F.W., de Mutsert R., van Dijk P.C., Zoccali C., Jager K.J. Survival analysis: time-dependent effects and time-varying risk factors. Kidney Int. 2008, 74:994-997.
39. Derian C.K., Santulli R.J., Tomko K.A., Haertlein B.J., Andrade-Gordon P. Species differences in platelet responses to thrombin and SFLLRN. receptor-mediated calcium mobilization and aggregation, and regulation by protein kinases. Thromb. Res. 1995, 78:505-519.
40. Deshmukh V.A., Tardif V., Lyssiotis C.A., Green C.C., Kerman B., Kim H.J., Padmanabhan K., Swoboda J.G., Ahmad I., Kondo T., et al. A regenerative approach to the treatment of multiple sclerosis. Nature 2013, 502:327-332.
41. Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 2007, 10:608-614.
42. Ding J.B., Takasaki K.T., Sabatini B.L. Supraresolution imaging in brain slices using stimulated-emission depletion two-photon laser scanning microscopy. Neuron 2009, 63:429-437.
43. Donnelly C.J., Zhang P.W., Pham J.T., Haeusler A.R., Mistry N.A., Vidensky S., Daley E.L., Poth E.M., Hoover B., Fines D.M., et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 2013, 80:415-428.
44. Ebert A.D., Yu J., Rose F.F., Mattis V.B., Lorson C.L., Thomson J.A., Svendsen C.N. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457:277-280.
45. Echeverri C.J., Perrimon N. High-throughput RNAi screening in cultured cells: a user's guide. Nat. Rev. Genet. 2006, 7:373-384.
46. Echeverri C.J., Beachy P.A., Baum B., Boutros M., Buchholz F., Chanda S.K., Downward J., Ellenberg J., Fraser A.G., Hacohen N., et al. Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat. Methods 2006, 3:777-779.
47. Egawa N., Kitaoka S., Tsukita K., Naitoh M., Takahashi K., Yamamoto T., Adachi F., Kondo T., Okita K., Asaka I., et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med. 2012, 4. 145ra104.
48. Eglen R., Reisine T. Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening. Assay Drug Dev. Technol. 2011, 9:108-124.
49. Emdad L., D'Souza S.L., Kothari H.P., Qadeer Z.A., Germano I.M. Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes. Stem Cells Dev. 2012, 21:404-410.
50. Falschlehner C., Steinbrink S., Erdmann G., Boutros M. High-throughput RNAi screening to dissect cellular pathways: a how-to guide. Biotechnol. J. 2010, 5:368-376.
51. Finkbeiner S. Huntington's disease. In Protein Homeostasis: The Chemistry and Biology of Diseases of Protein Conformation. The Cold Spring Harbor Perspectives in Biology Series 2012, 211-234. Cold Spring Harbor Press, New York. R.I. Morimoto, J.W. Kelly, D.J. Selkoe (Eds.).
52. Freddolino P.L., Tavazoie S. The dawn of virtual cell biology. Cell 2012, 150:248-250.
53. Garcia I., Huang L., Ung K., Arenkiel B.R. Tracing synaptic connectivity onto embryonic stem cell-derived neurons. Stem Cells 2012, 30:2140-2151.
54. Gilbert L.A., Larson M.H., Morsut L., Liu Z., Brar G.A., Torres S.E., Stern-Ginossar N., Brandman O., Whitehead E.H., Doudna J.A., et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 2013, 154:442-451.
55. Glory E., Murphy R.F. Automated subcellular location determination and high-throughput microscopy. Dev. Cell 2007, 12:7-16.
56. Grecco H.E., Verveer P.J. FRET in cell biology: still shining in the age of super-resolution?. ChemPhysChem 2011, 12:484-490.
57. Guo Y.S., Singh P., Upp J.R., Thompson J.C. Species-specific effects of neurotensin on gallbladder contraction invitro. Dig. Dis. Sci. 1989, 34:21-26.
58. Hamer G., Matilainen O., Holmberg C.I. A photoconvertible reporter of the ubiquitin-proteasome system invivo. Nat. Methods 2010, 7:473-478.
59. Hayes M., Zavazava N. Strategies to generate induced pluripotent stem cells. Methods Mol. Biol. 2013, 1029:77-92.
60. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 2012, 11:264-278. HD iPSC Consortium.
61. Israel M.A., Yuan S.H., Bardy C., Reyna S.M., Mu Y., Herrera C., Hefferan M.P., Van Gorp S., Nazor K.L., Boscolo F.S., et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012, 482:216-220.
62. Jin Z.B., Takahashi M. Generation of retinal cells from pluripotent stem cells. Prog. Brain Res. 2012, 201:171-181.
63. Jones T.R., Carpenter A.E., Lamprecht M.R., Moffat J., Silver S.J., Grenier J.K., Castoreno A.B., Eggert U.S., Root D.E., Golland P., Sabatini D.M. Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning. Proc. Natl. Acad. Sci. USA 2009, 106:1826-1831.
64. Kaelin W.G. Molecular biology. Use and abuse of RNAi to study mammalian gene function. Science 2012, 337:421-422.
65. Karr J.R., Sanghvi J.C., Macklin D.N., Gutschow M.V., Jacobs J.M., Bolival B., Assad-Garcia N., Glass J.I., Covert M.W. A whole-cell computational model predicts phenotype from genotype. Cell 2012, 150:389-401.
66. Kassner P.D. Discovery of novel targets with high throughput RNA interference screening. Comb. Chem. High Throughput Screen. 2008, 11:175-184.
67. Keshavaprasad B., Liu C., Au J.D., Kindler C.H., Cotten J.F., Yost C.S. Species-specific differences in response to anesthetics and other modulators by the K2P channel TRESK. Anesth. Analg. 2005, 101:1042-1049.
68. Kim J., Efe J.A., Zhu S., Talantova M., Yuan X., Wang S., Lipton S.A., Zhang K., Ding S. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc. Natl. Acad. Sci. USA 2011, 108:7838-7843.
69. Kim D.S., Ross P.J., Zaslavsky K., Ellis J. Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD. Front. Cell. Neurosci. 2014, 8:109.
70. Kopin A.S., McBride E.W., Gordon M.C., Quinn S.M., Beinborn M. Inter- and intraspecies polymorphisms in the cholecystokinin-B/gastrin receptor alter drug efficacy. Proc. Natl. Acad. Sci. USA 1997, 94:11043-11048.
71. Le Q.V., Ranzato M.A., Monga R., Devin M., Chen K., Corrado G.S., Dean J., Ng A.Y. Building high-level features using large scale unsupervised learning. Paper presented at: 29th International Conference on Machine Learning 2012, Edinburgh, Scotland, UK.
72. Levskaya A., Weiner O.D., Lim W.A., Voigt C.A. Spatiotemporal control of cell signalling using a light-switchable protein interaction. Nature 2009, 461:997-1001.
73. Li W., Xu Z., Huang J., Lin X., Luo R., Chen C.H., Shi P. NeuroArray: a universal interface for patterning and interrogating neural circuitry with single cell resolution. Sci. Rep. 2014, 4:4784.
74. Liang H., Matzkies M., Schunkert H., Tang M., Bonnemeier H., Hescheler J., Reppel M. Human and murine embryonic stem cell-derived cardiomyocytes serve together as a valuable model for drug safety screening. Cell. Physiol. Biochem. 2010, 25:459-466.
75. Lutolf M.P., Gilbert P.M., Blau H.M. Designing materials to direct stem-cell fate. Nature 2009, 462:433-441.
76. Maroof A.M., Keros S., Tyson J.A., Ying S.W., Ganat Y.M., Merkle F.T., Liu B., Goulburn A., Stanley E.G., Elefanty A.G., et al. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 2013, 12:559-572.
77. Mattson M.P., Rychlik B., You J.S., Sisken J.E. Sensitivity of cultured human embryonic cerebral cortical neurons to excitatory amino acid-induced calcium influx and neurotoxicity. Brain Res. 1991, 542:97-106.
78. McGonigle P. Animal models of CNS disorders. Biochem. Pharmacol. 2014, 87:140-149.
79. McGonigle P., Ruggeri B. Animal models of human disease: challenges in enabling translation. Biochem. Pharmacol. 2014, 87:162-171.
80. Miller J., Arrasate M., Shaby B.A., Mitra S., Masliah E., Finkbeiner S. Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis. J.Neurosci. 2010, 30:10541-10550.
81. Miller J., Arrasate M., Brooks E., Libeu C.P., Legleiter J., Hatters D., Curtis J., Cheung K., Krishnan P., Mitra S., et al. Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat. Chem. Biol. 2011, 7:925-934.
82. Miller J.D., Ganat Y.M., Kishinevsky S., Bowman R.L., Liu B., Tu E.Y., Mandal P.K., Vera E., Shim J.W., Kriks S., et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 2013, 13:691-705.
83. Mohr S., Bakal C., Perrimon N. Genomic screening with RNAi: results and challenges. Annu. Rev. Biochem. 2010, 79:37-64.
84. Morris M.C. Fluorescent biosensors of intracellular targets from genetically encoded reporters to modular polypeptide probes. Cell Biochem. Biophys. 2010, 56:19-37.
85. Mullane K., Williams M. Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?. Biochem. Pharmacol. 2013, 85:289-305.
86. Mullassery D., Horton C.A., Wood C.D., White M.R.H. Single live-cell imaging for systems biology. Essays Biochem. 2008, 45:121-133.
87. Murray J.I., Bao Z., Boyle T.J., Waterston R.H. The lineaging of fluorescently-labeled Caenorhabditis elegans embryos with StarryNite and AceTree. Nat. Protoc. 2006, 1:1468-1476.
88. Nagai Y., Inui T., Popiel H.A., Fujikake N., Hasegawa K., Urade Y., Goto Y., Naiki H., Toda T. A toxic monomeric conformer of the polyglutamine protein. Nat. Struct. Mol. Biol. 2007, 14:332-340.
89. Neumann B., Held M., Liebel U., Erfle H., Rogers P., Pepperkok R., Ellenberg J. High-throughput RNAi screening by time-lapse imaging of live human cells. Nat. Methods 2006, 3:385-390.
90. Neumann B., Walter T., Hériché J.K., Bulkescher J., Erfle H., Conrad C., Rogers P., Poser I., Held M., Liebel U., et al. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature 2010, 464:721-727.
91. Ogawa S., Tokumoto Y., Miyake J., Nagamune T. Induction of oligodendrocyte differentiation from adult human fibroblast-derived induced pluripotent stem cells. InVitro Cell. Dev. Biol. Anim. 2011, 47:464-469.
92. Okazaki R., Durham S.K., Riggs B.L., Conover C.A. Transforming growth factor-beta and forskolin increase all classes of insulin-like growth factor-I transcripts in normal human osteoblast-like cells. Biochem. Biophys. Res. Commun. 1995, 207:963-970.
93. Orvedahl A., Sumpter R., Xiao G., Ng A., Zou Z., Tang Y., Narimatsu M., Gilpin C., Sun Q., Roth M., et al. Image-based genome-wide siRNA screen identifies selective autophagy factors. Nature 2011, 480:113-117.
94. Osakada Y., Cui B. Real-time visualization of axonal transport in neurons. Methods Mol. Biol. 2011, 670:231-243.
95. Paige J.S., Nguyen-Duc T., Song W., Jaffrey S.R. Fluorescence imaging of cellular metabolites with RNA. Science 2012, 335:1194.
96. Palmer A.E., Qin Y., Park J.G., McCombs J.E. Design and application of genetically encoded biosensors. Trends Biotechnol. 2011, 29:144-152.
97. Penhoat A., Ouali R., Viard I., Langlois D., Saez J.M. Regulation of primary response and specific genes in adrenal cells by peptide hormones and growth factors. Steroids 1996, 61:176-183.
98. Perrin S. Preclinical research: Make mouse studies work. Nature 2014, 507:423-425.
99. Pfrieger F.W., Barres B.A. Synaptic efficacy enhanced by glial cells invitro. Science 1997, 277:1684-1687.
100. Pradier L., Habert-Ortoli E., Emile L., Le Guern J., Loquet I., Bock M.D., Clot J., Mercken L., Fardin V., Garret C., et al. Molecular determinants of the species selectivity of neurokinin type 1 receptor antagonists. Mol. Pharmacol. 1995, 47:314-321.
101. Prinz F., Schlange T., Asadullah K. Believe it or not: how muchcan we rely on published data on potential drug targets?. Nat. Rev. Drug Discov. 2011, 10:712.
102. Rasakham K., Liu-Chen L.Y. Sex differences in kappa opioid pharmacology. Life Sci. 2011, 88:2-16.
103. Richert L., Tuschl G., Viollon-Abadie C., Blanchard N., Bonet A., Heyd B., Halkic N., Wimmer E., Dolgos H., Mueller S.O. Species differences in the response of liver drug-metabolizing enzymes to (S)-4-O-tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric acid (EMD 392949) invivo and invitro. Drug Metab. Dispos. 2008, 36:702-714.
104. Sanders L.H., Laganière J., Cooper O., Mak S.K., Vu B.J., Huang Y.A., Paschon D.E., Vangipuram M., Sundararajan R., Urnov F.D., et al. LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neuralcells from Parkinson's disease patients: reversal by gene correction. Neurobiol. Dis. 2014, 62:381-386.
105. Sareen D., O'Rourke J.G., Meera P., Muhammad A.K., Grant S., Simpkinson M., Bell S., Carmona S., Ornelas L., Sahabian A., et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med. 2013, 5:208ra149.
106. Serio A., Bilican B., Barmada S.J., Ando D.M., Zhao C., Siller R., Burr K., Haghi G., Story D., Nishimura A.L., et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA 2013, 110:4697-4702.
107. Shalem O., Sanjana N.E., Hartenian E., Shi X., Scott D.A., Mikkelsen T.S., Heckl D., Ebert B.L., Root D.E., Doench J.G., Zhang F. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 2014, 343:84-87.
108. Shamir L., Delaney J.D., Orlov N., Eckley D.M., Goldberg I.G. Pattern recognition software and techniques for biological image analysis. PLoS Comput. Biol. 2010, 6:e1000974.
109. Sharma P., Ando D.M., Daub A., Kaye J.A., Finkbeiner S. High-throughput screening in primary neurons. Methods Enzymol. 2012, 506:331-360.
110. Sharma K., Choi S.Y., Zhang Y., Nieland T.J., Long S., Li M., Huganir R.L. High-throughput genetic screen for synaptogenic factors: identification of LRP6 as critical for excitatory synapse development. Cell Rep. 2013, 5:1330-1341.
111. Shein M., Greenbaum A., Gabay T., Sorkin R., David-Pur M., Ben-Jacob E., Hanein Y. Engineered neuronal circuits shaped and interfaced with carbon nanotube microelectrode arrays. Biomed. Microdevices 2009, 11:495-501.
112. Shein-Idelson M., Ben-Jacob E., Hanein Y. Engineered neuronal circuits: a new platform for studying the role of modular topology. Front Neuroeng. 2011, 4:10.
113. Shekhawat S.S., Ghosh I. Split-protein systems: beyond binary protein-protein interactions. Curr. Opin. Chem. Biol. 2011, 15:789-797.
114. Shi P., Scott M.A., Ghosh B., Wan D., Wissner-Gross Z., Mazitschek R., Haggarty S.J., Yanik M.F. Synapse microarray identification of small molecules that enhance synaptogenesis. Nat. Commun. 2011, 2:510.
115. Singh B., Gupta R.S. Species-specific differences in the toxicity and mutagenicity of the anticancer drugs mithramycin, chromomycin A3, and olivomycin. Cancer Res. 1985, 45:2813-2820.
116. Skibinski G., Nakamura K., Cookson M.R., Finkbeiner S. Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies. J.Neurosci. 2014, 34:418-433.
117. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G.W., Cook E.G., Hargus G., Blak A., Cooper O., Mitalipova M., et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136:964-977.
118. Studer L. Derivation of dopaminergic neurons from pluripotent stem cells. Prog. Brain Res. 2012, 200:243-263.
119. Sun Y., Sundararajan M. Axiomatic attribution for multilinear functions. arXiv.org 2011, 1-20.
120. Sun Y., Dong Z., Jin T., Ang K.H., Huang M., Haston K.M., Peng J., Zhong T.P., Finkbeiner S., Weiss W.A., et al. Imaging-based chemical screening reveals activity-dependent neural differentiation of pluripotent stem cells. eLife 2013, 2:e00508.
121. Sundberg M., Bogetofte H., Lawson T., Jansson J., Smith G., Astradsson A., Moore M., Osborn T., Cooper O., Spealman R., et al. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells 2013, 31:1548-1562.
122. Swearingen E.A., Fajardo F., Wang X., Watson J.E., Quon K.C., Kassner P.D. Use of cryopreserved cell aliquots in the high-throughput screening of small interfering RNA libraries. J.Biomol. Screen. 2010, 15:469-477.
123. Tainaka K., Sakaguchi R., Hayashi H., Nakano S., Liew F.F., Morii T. Design strategies of fluorescent biosensors based on biological macromolecular receptors. Sensors (Basel) 2010, 10:1355-1376.
124. Takahashi K., Yamanaka S. Induction of pluripotent stem cellsfrom mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
125. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult humanfibroblasts by defined factors. Cell 2007, 131:861-872.
126. Tsvetkov A.S., Arrasate M., Barmada S., Ando D.M., Sharma P., Shaby B.A., Finkbeiner S. Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. Nat. Chem. Biol. 2013, 9:586-592.
127. Ullian E.M., Sapperstein S.K., Christopherson K.S., Barres B.A. Control of synapse number by glia. Science 2001, 291:657-661.
128. Vendrell M., Lee J.-S., Chang Y.-T. Diversity-oriented fluorescence library approaches for probe discovery and development. Curr. Opin. Chem. Biol. 2010, 14:383-389.
129. Victor M.B., Richner M., Hermanstyne T.O., Ransdell J.L., Sobieski C., Deng P.Y., Klyachko V.A., Nerbonne J.M., Yoo A.S. Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. Neuron 2014, 84:311-323.
130. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Südhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
131. Vinkenborg J.L., Koay M.S., Merkx M. Fluorescent imaging of transition metal homeostasis using genetically encoded sensors. Curr. Opin. Chem. Biol. 2010, 14:231-237.
132. Walter T., Held M., Neumann B., Hériché J.-K., Conrad C., Pepperkok R., Ellenberg J. Automatic identification and clustering of chromosome phenotypes in a genome wide RNAi screen by time-lapse imaging. J.Struct. Biol. 2010, 170:1-9.
133. Wang S., Bates J., Li X., Schanz S., Chandler-Militello D., Levine C., Maherali N., Studer L., Hochedlinger K., Windrem M., Goldman S.A. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 2013, 12:252-264.
134. Wang T., Wei J.J., Sabatini D.M., Lander E.S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 2014, 343:80-84.
135. Warren L., Manos P.D., Ahfeldt T., Loh Y.-H., Li H., Lau F., Ebina W., Mandal P.K., Smith Z.D., Meissner A., et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7:618-630.
136. Wen X., Tan W., Westergard T., Krishnamurthy K., Markandaiah S.S., Shi Y., Lin S., Shneider N.A., Monaghan J., Pandey U.B., et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate invitro and invivo neuronal death. Neuron 2014, 84:1213-1225.
137. Wen Z., Nguyen H.N., Guo Z., Lalli M.A., Wang X., Su Y., Kim N.S., Yoon K.J., Shin J., Zhang C., et al. Synaptic dysregulation in a human iPS cell model of mental disorders. Nature 2014, 515:414-418.
138. Wolfe R.A., Strawderman R.L. Logical and statistical fallacies in the use of Cox regression models. Am. J. Kidney Dis. 1996, 27:124-129.
139. Wray S., Self M., Lewis P.A., Taanman J.W., Ryan N.S., Mahoney C.J., Liang Y., Devine M.J., Sheerin U.M., Houlden H., et al. Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLoS ONE 2012, 7:e43099. NINDS Parkinson's Disease iPSC Consortium, NINDS Huntington's Disease iPSC ConsortiumNINDS Huntington's Disease iPSC Consortium, NINDS ALS iPSC ConsortiumNINDS ALS iPSC Consortium.
140. Wu B., Piatkevich K.D., Lionnet T., Singer R.H., Verkhusha V.V. Modern fluorescent proteins and imaging technologies to study gene expression, nuclear localization, and dynamics. Curr. Opin. Cell Biol. 2011, 23:310-317.
141. Xie W., Barwick J.L., Downes M., Blumberg B., Simon C.M., Nelson M.C., Neuschwander-Tetri B.A., Brunt E.M., Guzelian P.S., Evans R.M. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 2000, 406:435-439.
142. Yang N., Zuchero J.B., Ahlenius H., Marro S., Ng Y.H., Vierbuchen T., Hawkins J.S., Geissler R., Barres B.A., Wernig M. Generation of oligodendroglial cells by direct lineage conversion. Nat. Biotechnol. 2013, 31:434-439.
143. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
144. Zhang N., An M.C., Montoro D., Ellerby L.M. Characterization of human Huntington's disease cell model from induced pluripotent stem cells. PLoS Curr. 2010, 2:RRN1193.
145. Zhang K., Osakada Y., Xie W., Cui B. Automated image analysis for tracking cargo transport in axons. Microsc. Res. Tech. 2011, 74:605-613.
146. Zhang F., Wen Y., Guo X. CRISPR/Cas9 for genome editing: progress, implications and challenges. Hum. Mol. Genet. 2014, 23(R1):R40-R46.
147. Zhu S., Ambasudhan R., Sun W., Kim H.J., Talantova M., Wang X., Zhang M., Zhang Y., Laurent T., Parker J., et al. Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells. Cell Res. 2014, 24:126-129.